GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Cognex Corporation (CGNX) Chairman of the Board Robert J Shillman sells 9,611 Shares

November 15, 2012 | About:
insider

insider

57 followers
Chairman of the Board of Cognex Corporation (CGNX) Robert J Shillman sells 9,611 shares of CGNX on 11/14/2012 at an average price of $35.02 a share.

Cognex Corporation has a market cap of $1.5 billion; its shares were traded at around $33.4 with a P/E ratio of 21.5 and P/S ratio of 4.7. The dividend yield of Cognex Corporation stocks is 1.3%.

This is the annual revenues and earnings per share of CGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CGNX.


CEO Recent Trades:



  • CEO& President Robert Willett sold 17,500 shares of CGNX stock on 11/05/2012 at the average price of 36.59. The price of the stock has decreased by 8.72% since.

CFO Recent Trades:



  • Sr. VP F&A, CFO Richard Morin sold 1,586 shares of CGNX stock on 09/11/2012 at the average price of 38.29. Richard Morin owns at least 999 shares after this. The price of the stock has decreased by 12.77% since.

This is the insider trade history vs. stock price of CGNX. For the complete insider trading history of CGNX, click here.




Directors and Officers Recent Trades:



  • Chairman of the Board Robert J Shillman sold 9,611 shares of CGNX stock on 11/14/2012 at the average price of 35.02. Robert J Shillman owns at least 3,253,695 shares after this. The price of the stock has decreased by 4.63% since.


For the complete insider trading history of CGNX, click here.

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK